Fentanyl treatment for end-of-life dyspnoea relief in advanced cancer patients

@article{BentezRosario2018FentanylTF,
  title={Fentanyl treatment for end-of-life dyspnoea relief in advanced cancer patients},
  author={Miguel Angel Ben{\'i}tez-Rosario and Inmaculada Rosa-Gonz{\'a}lez and Enrique Gonz{\'a}lez-D{\'a}vila and Emilio Jos{\'e} Sanz},
  journal={Supportive Care in Cancer},
  year={2018},
  volume={27},
  pages={157-164}
}
PurposeWe assessed the effects of subcutaneous-endovenous fentanyl on dyspnoea in a cohort of advanced cancer patients.MethodsWe performed a retrospective study in a cohort of advanced cancer patients with dyspnoea at rest who received subcutaneous or intravenous fentanyl. Patients with no shortness of breath at rest or at minimal exertion, no rescue doses per 24 h, were deemed to be responders to fentanyl. The period of assessment was 6 days from the beginning of fentanyl treatment… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES